Perinatal Depression and Adverse Childhood Experiences: Prevention Trial
Key facts
- Who runs it
- Northwestern University
- Where
- Chicago, United StatesSee the site
- Trial code
- Status
- Active, not recruiting
- People taking part
- 76 people, planned
- Started
- 20 Jul 2023
- Ended
- 31 Oct 2026
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Reach Out, Stand Strong, Essentials for New Mothers (ROSE) Program
- Record updated
- 22 July 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women only
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- Age ≥ 18 years
- At least one prenatal visit at Northwestern Medicine
- Less than 24 weeks gestation
- Non-anomalous pregnancy
- English- or Spanish- speaking
- ACE score ≥ 2
- Singleton gestation
Who cannot take part
- Active substance use disorder
- Intent to delivery outside of Prentice Women's Hospital
- Active major depressive episode
- Participation in a study with a competing intervention or outcome
Where in United States
- Northwestern MedicineChicago, United States
About the trial
What the trial wants to find out
The goal of this clinical trial is to evaluate the impact of ROSE in individuals with adverse childhood experiences. The main question it aims to answer is, compared to enhanced treatment as usual, does the delivery of ROSE within a collaborative care model improve depressive symptom trajectories and prevent the development of perinatal depression.
Read full original descriptionShow less
Participants will be randomized to either enhanced treatment as usual or the ROSE intervention, delivered by a care manager within a perinatal collaborative care program. They will complete self-reported surveys of their depression symptoms every 4 weeks to inform their symptom trajectories. They will also complete clinical interviews to establish any incident diagnoses of a major depressive episode.
The 2 groups in the trial
- Enhanced treatment as usualNo study treatment, for comparison
Those randomized to enhanced treatment as usual will receive brief psychoeducation about perinatal depression and the associations between ACEs and perinatal depression. Information about the collaborative care program will be provided. Individuals will be followed with monthly self-reported screens for depression, without any prevention programming for perinatal depression. Those identified to have incident depression symptoms will receive recommendations for treatment within the collaborative care model.
- ROSE interventionTreatment being tested
Those randomized to the intervention will be offered 4 prenatal sessions and one postpartum "booster" session guided by the Reach Out, Stand Strong, Essentials for New Mothers (ROSE) program embedded within the collaborative care model. Participants will be followed with monthly self-reported screens for depression, and those identified to have incident depression symptoms will receive treatment within the collaborative care model.
Treatment: Reach Out, Stand Strong, Essentials for New Mothers (ROSE) Program
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Prevention of Perinatal Depression in Birthing People With a History of Adverse Childhood Experiences: A Type 2 Effectiveness Implementation Trial
- Record updated
- 22 July 2026